IL-17 ANTIBODY FORMULATION
The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
Saved in:
| Main Authors | , , , |
|---|---|
| Format | Patent |
| Language | English Polish |
| Published |
30.06.2017
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma. |
|---|---|
| AbstractList | The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma. |
| Author | MARKHAM AARON PAUL WILLIAMS BARBARA ANN CORVARI VINCENT JOHN DONOVAN PATRICK DANIEL |
| Author_xml | – fullname: CORVARI VINCENT JOHN – fullname: WILLIAMS BARBARA ANN – fullname: DONOVAN PATRICK DANIEL – fullname: MARKHAM AARON PAUL |
| BookMark | eNrjYmDJy89L5WSQ8vTRNTRXcPQL8XTyd4lUcPMP8g31cQzx9PfjYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxAT5GFkZGppYGISHGxsSoAQD5ySJV |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | Preparat przeciwciała przeciwko IL-17 |
| ExternalDocumentID | PL2822590TT3 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_PL2822590TT33 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:54:42 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Polish |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_PL2822590TT33 |
| Notes | Application Number: PL20130710214T |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170630&DB=EPODOC&CC=PL&NR=2822590T3 |
| ParticipantIDs | epo_espacenet_PL2822590TT3 |
| PublicationCentury | 2000 |
| PublicationDate | 20170630 |
| PublicationDateYYYYMMDD | 2017-06-30 |
| PublicationDate_xml | – month: 06 year: 2017 text: 20170630 day: 30 |
| PublicationDecade | 2010 |
| PublicationYear | 2017 |
| RelatedCompanies | Eli Lilly and Company |
| RelatedCompanies_xml | – name: Eli Lilly and Company |
| Score | 3.102084 |
| Snippet | The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | IL-17 ANTIBODY FORMULATION |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170630&DB=EPODOC&locale=&CC=PL&NR=2822590T3 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTEyMQYtLtRNskxM1DVJtbDUTTK1BGY8YxNg5ZSSZpYIntH19TPzCDXxijCNYGLIhO2FAZ8TWg4-HBGYo5KB-b0EXF4XIAaxXMBrK4v1kzKBQvn2biG2LmrQ3jHoLBhjAzUXJ1vXAH8Xf2c1Z2fbAB81vyBb0GpJU0uDEGNmBlZQKxp0zL5rmBNoU0oBco3iJsjAFgA0LK9EiIGpIEeYgdMZdvGaMAOHL3S-G8iEZr1iEQYpTx9dQ3MFR78QTyd_l0gFYO_NN9QHPMIkyqDo5hri7KELtCQe7qH4AB-Yc0KMjcUYWIAd_VQJBgWLJIs0c9MkY7OkpDSTNCMLC5OUNCMD82QL8ySTRKPUNEkGKdzmSOGTlGbgAgUOZJ2bDANLSVFpqiywMi1JkgMHAwBW23YE |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD7MKc43ncqstwrSt2Jt0ttDEduutNobksl8Ks3WwkC0uIp_3zS26ou-hQROkgNfDt-5BeASqxi1yYUytYpCxqVpyVSzGPAQZsZpWekFj-jGiR7M8N1cmw9g1dfC8D6hH7w5IkPUguG94e91_ePE8nhu5fqKrtjU641PbE_q2HHbCwYpkufY0yz1UldyXTuLpOTBbrMlNUshaAM2DcYIOVN6dNqilPq3RfF3YStjwl6aPRjUz2MYuf3Ha2PYjrt4Nxt20FvvgxBG8rUh3iYkdFLvSWTsLZ5F3MN0ABf-lLiBzDbJvy-UZ1F_HILQIQwZ0S8nIJrUrAyNIp3SCleqaeJlpSrGwjQoLtSyOgLhbznCf4vnMApIHOVRmNwfw06rqK-ctxMYNm_v5SkzrA094yr5BAAdeO4 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=IL-17+ANTIBODY+FORMULATION&rft.inventor=CORVARI+VINCENT+JOHN&rft.inventor=WILLIAMS+BARBARA+ANN&rft.inventor=DONOVAN+PATRICK+DANIEL&rft.inventor=MARKHAM+AARON+PAUL&rft.date=2017-06-30&rft.externalDBID=T3&rft.externalDocID=PL2822590TT3 |